In EVs derived from blood plasma, a correlation between C4BPA, modulation of the tumor microenvironment, and immune escape through the complement system has been suggested in patients with hepatocellular carcinoma, showing a higher abundance of C4BPA compared to control patients [85]. This evidence concerns the gene C4BPA and hepatocellular carcinoma.